Dong-A ST Co., Ltd.
KRX:170900.KS
76,600 (KRW) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Dong-A ST Co., Ltd. |
Symbool | 170900.KS |
Munteenheid | KRW |
Prijs | 76,600 |
Beurswaarde | 687,707,446,400 |
Dividendpercentage | 1.06% |
52-weken bereik | 53,725.5 - 88,000 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Min-Young Kim |
Website | https://www.donga-st.com |
An error occurred while fetching data.
Over Dong-A ST Co., Ltd.
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products and medical devices worldwide. It offers various ethical drugs, including Closerin for active pulmonary and extra-pulmonary tuberculosis; Dulastin and Leucostim for neutropenia in patients receiving myelosuppressive chemotherapy; Eporon for anemia associated with chronic renal failure; Gemcit for non-small cell lung,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)